Penumbra

Penumbra's 15-min chart indicates MACD Death Cross, BB expanding downward.

Penumbra's 15min chart shows Bollinger Bands expanding downward with KDJ death cross.

Boston Scientific

Boston Scientific (BSX) Surges Amid Penumbra Acquisition, Analysts Bullish on Future Growth

Boston Scientific's Valuation After Penumbra Deal and Recent Share Moves: A Closer Look

Catalyst<ul> <li>Recent bullish signals such as the Long Lower Shadow on January 13 suggest potential short-term rebound momentum.</li> <li>Fund flows show positive trends across Small, Medium, and Large order sizes indicating investor confidence.</li></ul>Risk<ul> <li>The technical outlook is weak with bearish signals outnumbering bullish ones (4 bearish vs 1 bullish).</li> <li>Analyst ratings are largely Neutral with only one Strong Buy, indicating a cautious institutional stance.</li></ul>

Key Factors

Penumbra's stock surged 11.8% following its Q4 earnings report on January 15, 2026, with shares rising 29.3% to near $342 by the subsequent period. On February 5, 2026, Penumbra's stock (PEN) closed up 0.61% amid a $640 million trading volume surge, ranking 251st in market activity.

PEN News